Jane G. Farrar
Gründer bei Spark Therapeutics Ireland Ltd.
Ursprung des Netzwerks ersten Grades von Jane G. Farrar
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Trinity College Dublin
18
| College/University | Other Consumer Services | 18 |
American Society of Gene & Cell Therapy
 American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay.
12
| Private Company | Miscellaneous Commercial Services | 12 |
Spark Therapeutics Ireland Ltd.
 Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jane G. Farrar
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
SICOR, Inc.
 SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | Pharmaceuticals: Major | General Counsel | |
Santarus, Inc.
 Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | General Counsel | |
Bruin Pharma, Inc.
 Bruin Pharma, Inc. Pharmaceuticals: MajorHealth Technology Bruin Pharma, Inc. develops pharmaceutical preparations. The company is headquartered in Beverly Hills, CA. | Pharmaceuticals: Major | General Counsel | |
Clearstream Technologies Group Ltd.
 Clearstream Technologies Group Ltd. Medical SpecialtiesHealth Technology Clearstream Technologies Group develops and manufactures medical devices. It develops, manufactures and markets medical devices used by interventional cardiologists, radiologists, and vascular surgeons in angioplasty procedures. The company was founded in 1996 and is headquartered in Enniscorthy, Ireland. | Medical Specialties | Director/Board Member | |
Regulatory Affairs Professionals Society
 Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Regulatory Affairs Professionals Society is a non-profit organization that offers healthcare products. The non-profit company is based in Rockville, MD. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Fountain Healthcare Partners Ltd.
 Fountain Healthcare Partners Ltd. Investment ManagersFinance Fountain Healthcare Partners Ltd. (Fountain) is venture capital firm, founded in 2008 by Manus Rogan and Aidan King. The firm is headquartered in Dublin, Ireland. | Investment Managers | Private Equity Investor | |
| Boston College | College/University | Undergraduate Degree | |
| The Johns Hopkins University | College/University | Corporate Officer/Principal Doctorate Degree | |
AstraZeneca Canada, Inc.
 AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University Of Dundee | College/University | Doctorate Degree | |
| University College Dublin | College/University | Undergraduate Degree Corporate Officer/Principal Masters Business Admin | |
| University of Birmingham | College/University | Undergraduate Degree | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Parenteral Drug Association | Corporate Officer/Principal | ||
| IVERIC BIO, INC. | Pharmaceuticals: Generic | Corporate Officer/Principal Corporate Officer/Principal | |
Cellix Ltd.
 Cellix Ltd. Medical SpecialtiesHealth Technology Cellix Ltd. develops microfluidic pumping solutions, consumable biochips, software, and automated solutions. It offers its solutions for applications in cell biology, microfluidics and nanofluidics, physics, chemistry, cell, and particle studies. The company was founded by Dmitry Kashanin, Vivienne Williams, Francis Odowd, and Igor Shvets in 2004 and is headquartered in Dublin, Ireland. | Medical Specialties | Director/Board Member Founder | |
| Glaxo Group Research Ltd. | Corporate Officer/Principal | ||
Celentyx Ltd.
 Celentyx Ltd. BiotechnologyHealth Technology Celentyx Ltd. provides research and development on human immune disease. The firm's services include rapid analysis screening of drug action on physiological and pathological human immune tissues and cells. It provides services by disease, cell type, assay through its ImmuKnowlogy platform technology. The company was founded by Nicholas Mark Barnes and John Gordon in 2004 and is headquartered in Birmingham, the United Kingdom. | Biotechnology | Director/Board Member | |
| Royal Irish Academy | College/University | Corporate Officer/Principal | |
Science Foundation Ireland
 Science Foundation Ireland Miscellaneous Commercial ServicesCommercial Services Science Foundation Ireland funds oriented basic and applied research in the areas of science, technology, engineering, and mathematics (STEM). It promotes and supports the study of, education in, and engagement with STEM and promotes an awareness and understanding of the value of STEM to society. The company was founded in 1998 and is headquartered in Dublin, Ireland,. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Nuvotem Teoranta
 Nuvotem Teoranta Electronic ComponentsElectronic Technology Nuvotem Teoranta is an Irish company that specializes in the manufacturing and sale of toroidal transformers and other magnetic components. | Electronic Components | Corporate Officer/Principal | |
| LM Ericsson Holding AB | Chairman | ||
Intel Ireland Ltd.
 Intel Ireland Ltd. Packaged SoftwareTechnology Services Intel Ireland Ltd. designs and builds the essential technologies that serve as the foundation for the world's computing devices. The company was founded in 1989 and is headquartered in Leixlip, Ireland. | Packaged Software | Corporate Officer/Principal | |
Zeneca Pharmaceuticals
 Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Zeneca Pharmaceuticals manufactures medicines. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| UMass Chan Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Chief Executive Officer Director/Board Member | |
| Centre for Research on Nutrition Support Systems | Director/Board Member | ||
American Chamber of Commerce Ireland
 American Chamber of Commerce Ireland Miscellaneous Commercial ServicesCommercial Services The American Chamber of Commerce Ireland is a leading international business organization that supports the Transatlantic business relationship. The non-profit company is based in Dublin, Ireland. The Irish company provides networking opportunities, leadership development programs, and representation to government, media, and stakeholders. The company's highly sought-after programs operate virtually and in person, supporting individual growth within their member companies. The CEO of the company is Mark Redmond. | Miscellaneous Commercial Services | President | |
| Alan Boyd Consultants Ltd. | Chief Executive Officer | ||
Biocroi Ltd.
 Biocroi Ltd. BiotechnologyHealth Technology Biocroi Ltd. designs and develops advanced microplates which solve the problems that have irritated plate users. Its products include thermal buffering, cellular quality, anti evaporation, edge effects, reproductivity of 50nl spotting, miniaturization of siRNA assays, preprinted siRNA nano arrays, anti evaporation of 100nl droplets in the ADVANCE384 and happy cell. The firm also offers services like high content screening, flow cytometry, biiorepository, DNA extraction services and bespoke assay plates. The company was founded in 2009 and is headquartered in Dublin, Ireland. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| CLINIGEN GROUP PLC | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
TriMod Therapeutics Ltd.
 TriMod Therapeutics Ltd. BiotechnologyHealth Technology TriMod Therapeutics Ltd develops novel platform technologies to treat cancer and autoimmune diseases. It offers TriMoVac technology that enhances the patients' immune response to the tumour and promotes its eradication by attenuating its' immune subversion strategies. The company was founded by Kingston Mills and Jeremy Skillingtonand in 2011 is headquartered in Dublin, Ireland. | Biotechnology | Founder | |
NeRRe Therapeutics Ltd.
 NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services NeRRe Therapeutics Ltd. provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity. It develops neurokinin receptor antagonists acquired from GlaxoSmithKline. The company was founded by Emiliangelo Ratti and Mike Trower in 2012 and is headquartered in Stevenage, the United Kingdom. | Medical Distributors | Director/Board Member | |
| EDITAS MEDICINE, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Founder Corporate Officer/Principal | |
| Irish College of Ophthalmologists | College/University | Corporate Officer/Principal | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | General Counsel | |
Linear Diagnostics Ltd.
 Linear Diagnostics Ltd. Medical SpecialtiesHealth Technology Linear Diagnostics Ltd. operates as a diagnostics company based on a novel technology that allows wide range of molecular diagnostics tests to be carried out using a simple optical system. It specializes in molecular diagnostics, novel technology and optical detection. The company was founded by Matt Hicks in 2011 and is headquartered in Birmingham, the United Kingdom. | Medical Specialties | Director/Board Member | |
Transine Therapeutics Ltd.
 Transine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Transine Therapeutics Ltd. is an RNA platform company based in Cambridge, UK. The British company is developing a novel class of therapeutic RNAs called SINEUPs, which can upregulate protein expression with a superior level of control and specificity across an unprecedented range of diseases and applications. The company's proprietary technology allows them to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies. The SINEUP platform boosts the expression of almost any chosen target protein by binding precisely to the mRNA that encodes it and enhancing its translation. This technology massively extends the druggable proteome and represents an entirely new mechanism of action, ideally suited to address currently hard-to-treat diseases. The company was founded in 2018 by Stefano Gustincich and Piero Carninci. Jan Thirkettle has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
| International Council For Scientific & Technical Information | Corporate Officer/Principal | ||
| CRANN | Director/Board Member | ||
| Institution of Engineers of Ireland | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 19 |
| Irland | 18 |
| Vereinigtes Königreich | 13 |
| Kanada | 2 |
| Schweden | 2 |
Sektoral
| Health Technology | 22 |
| Consumer Services | 10 |
| Commercial Services | 6 |
| Electronic Technology | 4 |
| Finance | 2 |
Operativ
| Director/Board Member | 116 |
| Corporate Officer/Principal | 90 |
| Founder | 29 |
| Undergraduate Degree | 19 |
| Chairman | 19 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Arun Kumar Nanda | 43 |
| Joey Mason | 31 |
| John Monahan | 17 |
| Ian St. John Cahill | 16 |
| Thomas Ciulla | 15 |
| Ena Prossner | 14 |
| Shamim Ruff | 12 |
| Alan Keith Boyd | 12 |
| Debra Gessner | 12 |
| Pradeep Kar | 11 |
| Luigi Naldini | 11 |
| Timothy D. Hunt | 10 |
| Alan Cooke | 10 |
| Dylan Collins | 9 |
| Louise Rodino-Klapac | 9 |
- Börse
- Insiders
- Jane G. Farrar
- Unternehmensverbindungen
